Evidence map›Paper›PMID 37249986›Full record

ReviewFrontiers in cellular and infection microbiology2023

An update on recent progress of the epidemiology, etiology, diagnosis, and treatment of acute septic arthritis: a review.

Miao He, Djandan Tadum Arthur Vithran, Linyuan Pan, Haijin Zeng, Guang Yang, Bangbao Lu, Fangjie Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. AcuteThe Journal of international medical research · 2026
    Article
  4. Review
  5. Comparative Analysis of Methicillin-SusceptibleAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Miao HeDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Djandan Tadum Arthur VithranDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Linyuan PanDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Haijin ZengDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Guang YangDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Bangbao LuDepartment of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Fangjie ZhangNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute septic arthritis is on the rise among all patients. Acute septic arthritis must be extensively assessed, identified, and treated to prevent fatal consequences. Antimicrobial therapy administered intravenously has long been considered the gold standard for treating acute osteoarticular infections. According to clinical research, parenteral antibiotics for a few days, followed by oral antibiotics, are safe and effective for treating infections without complications. This article focuses on bringing physicians up-to-date on the most recent findings and discussions about the epidemiology, etiology, diagnosis, and treatment of acute septic arthritis. In recent years, the emergence of antibiotic-resistant, particularly aggressive bacterial species has highlighted the need for more research to enhance treatment approaches and develop innovative diagnosis methods and drugs that might combat better in all patients. This article aims to furnish radiologists, orthopaedic surgeons, and other medical practitioners with contemporary insights on the subject matter and foster collaborative efforts to improve patient outcomes. This review represents the initial comprehensive update encompassing patients across all age groups.

Indexed as

Anti-Infective AgentsArthritis, InfectiousAnti-Bacterial AgentsCausalityHumansRetrospective StudiesAnti-Bacterial AgentsAnti-Infective AgentsantibioticsarthroscopyepidemiologyPathogenic microorganismseptic arthritis

Identifiers

PMID37249986
PMCPMC10214960
OpenAlexW4367678806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.